Cynthia Tsay1, Dennis Shung1, Katherine Stemmer Frumento1, Loren Laine2. 1. Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut. 2. Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut; VA Connecticut Healthcare System, West Haven, Connecticut. Electronic address: loren.laine@yale.edu.
Abstract
BACKGROUND & AIMS: Guidelines recommend colonoscopy evaluation within 24 hours of presentation or admission in patients with high-risk or severe acute lower gastrointestinal bleeding (LGIB). Meta-analyses of the timing of colonoscopy have relied primarily on observational studies that had major potential for bias. We performed a systematic review of randomized trials to determine optimal timing of colonoscopy for patients hospitalized with acute LGIB. METHODS: We searched publication databases through July 2019 and abstracts from gastroenterology meetings through November 2019 for randomized trials of patients with acute LGIB or hematochezia. We searched for studies that compared early colonoscopy (within 24 hours) with elective colonoscopy beyond 24 hours and/or other diagnostic tests. Our primary outcome was further bleeding, defined as persistent or recurrent bleeding after index examination. Secondary outcomes included mortality, diagnostic yield (identifying source of bleeding), endoscopic intervention, and any primary hemostatic intervention (endoscopic, surgical, or interventional radiologic). We performed dual independent review, data extraction, and risk of bias assessments. We performed the meta-analysis using a random-effects model. RESULTS: Our final analysis included data from 4 randomized trials. Further bleeding was not decreased among patients who received early vs later, elective colonoscopy (relative risk [RR] for further bleeding with early colonoscopy, 1.57; 95% CI. 0.74-3.31). We did not find significant differences in the secondary outcomes of mortality (RR, 0.93; 95% CI, 0.05-17.21), diagnostic yield (RR, 1.09; 95% CI, 0.99-1.21), endoscopic intervention (RR, 1.53; 95% CI, 0.67-3.48), or any primary hemostatic intervention (RR, 1.33; 95% CI, 0.92-1.92). CONCLUSIONS: In a meta-analysis of randomized trials, we found that colonoscopy within 24 hours does not reduce further bleeding or mortality in patients hospitalized with acute LGIB. Based on these findings, patients hospitalized with acute LGIB do not generally require early colonoscopy.
BACKGROUND & AIMS: Guidelines recommend colonoscopy evaluation within 24 hours of presentation or admission in patients with high-risk or severe acute lower gastrointestinal bleeding (LGIB). Meta-analyses of the timing of colonoscopy have relied primarily on observational studies that had major potential for bias. We performed a systematic review of randomized trials to determine optimal timing of colonoscopy for patients hospitalized with acute LGIB. METHODS: We searched publication databases through July 2019 and abstracts from gastroenterology meetings through November 2019 for randomized trials of patients with acute LGIB or hematochezia. We searched for studies that compared early colonoscopy (within 24 hours) with elective colonoscopy beyond 24 hours and/or other diagnostic tests. Our primary outcome was further bleeding, defined as persistent or recurrent bleeding after index examination. Secondary outcomes included mortality, diagnostic yield (identifying source of bleeding), endoscopic intervention, and any primary hemostatic intervention (endoscopic, surgical, or interventional radiologic). We performed dual independent review, data extraction, and risk of bias assessments. We performed the meta-analysis using a random-effects model. RESULTS: Our final analysis included data from 4 randomized trials. Further bleeding was not decreased among patients who received early vs later, elective colonoscopy (relative risk [RR] for further bleeding with early colonoscopy, 1.57; 95% CI. 0.74-3.31). We did not find significant differences in the secondary outcomes of mortality (RR, 0.93; 95% CI, 0.05-17.21), diagnostic yield (RR, 1.09; 95% CI, 0.99-1.21), endoscopic intervention (RR, 1.53; 95% CI, 0.67-3.48), or any primary hemostatic intervention (RR, 1.33; 95% CI, 0.92-1.92). CONCLUSIONS: In a meta-analysis of randomized trials, we found that colonoscopy within 24 hours does not reduce further bleeding or mortality in patients hospitalized with acute LGIB. Based on these findings, patients hospitalized with acute LGIB do not generally require early colonoscopy.
Authors: Shabana F Pasha; Amandeep Shergill; Ruben D Acosta; Vinay Chandrasekhara; Krishnavel V Chathadi; Dayna Early; John A Evans; Deborah Fisher; Lisa Fonkalsrud; Joo Ha Hwang; Mouen A Khashab; Jenifer R Lightdale; V Raman Muthusamy; John R Saltzman; Brooks D Cash Journal: Gastrointest Endosc Date: 2014-04-02 Impact factor: 9.427
Authors: Stig B Laursen; Grigorios I Leontiadis; Adrian J Stanley; Morten H Møller; Jane M Hansen; Ove B Schaffalitzky de Muckadell Journal: Gastrointest Endosc Date: 2016-09-10 Impact factor: 9.427
Authors: Bryan T Green; Don C Rockey; G Portwood; Paul R Tarnasky; Steve Guarisco; Malcolm S Branch; Joseph Leung; Paul Jowell Journal: Am J Gastroenterol Date: 2005-11 Impact factor: 10.864
Authors: Neil Sengupta; Elliot B Tapper; Vilas R Patwardhan; Gyanprakash A Ketwaroo; Adarsh M Thaker; Daniel A Leffler; Joseph D Feuerstein Journal: Mayo Clin Proc Date: 2015-07-02 Impact factor: 7.616
Authors: Ira Roshan Afshar; Mo Seyed Sadr; Lisa L Strate; Myriam Martel; Charles Menard; Alan N Barkun Journal: Therap Adv Gastroenterol Date: 2018-02-19 Impact factor: 4.409
Authors: Neena S Abraham; Alan N Barkun; Bryan G Sauer; James Douketis; Loren Laine; Peter A Noseworthy; Jennifer J Telford; Grigorios I Leontiadis Journal: J Can Assoc Gastroenterol Date: 2022-03-17
Authors: Kalpit Devani; Dhruvil Radadiya; Paris Charilaou; Tyler Aasen; Chakradhar M Reddy; Mark Young; Bhaumik Brahmbhatt; Don C Rockey Journal: Endosc Int Open Date: 2021-05-27
Authors: Amrita Sethi; Arun Swaminath; Melissa Latorre; Daniel S Behin; Daniela Jodorkovsky; Delia Calo; Olga Aroniadis; Anjali Mone; Robin B Mendelsohn; Reem Z Sharaiha; Tamas A Gonda; Lauren G Khanna; Juan Carlos Bucobo; Satish Nagula; Sammy Ho; David L Carr-Locke; David H Robbins Journal: Clin Gastroenterol Hepatol Date: 2020-04-21 Impact factor: 11.382
Authors: Shahnaz Sultan; Joseph K Lim; Osama Altayar; Perica Davitkov; Joseph D Feuerstein; Shazia M Siddique; Yngve Falck-Ytter; Hashem B El-Serag Journal: Gastroenterology Date: 2020-04-01 Impact factor: 22.682